| Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated … G Eisenhofer, A Prejbisz, M Peitzsch, C Pamporaki, J Masjkur, ... Clinical chemistry 64 (11), 1646-1656, 2018 | 181 | 2018 |
| Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas C Pamporaki, B Hamplova, M Peitzsch, A Prejbisz, F Beuschlein, ... The Journal of Clinical Endocrinology & Metabolism 102 (4), 1122-1132, 2017 | 166 | 2017 |
| Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: impact of gender, age, oral contraceptives, body mass index and blood pressure status G Eisenhofer, M Peitzsch, D Kaden, K Langton, C Pamporaki, J Masjkur, ... Clinica Chimica Acta 470, 115-124, 2017 | 164 | 2017 |
| Biochemical diagnosis of phaeochromocytoma using plasma‐free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions R Därr, C Pamporaki, M Peitzsch, K Miehle, A Prejbisz, M Peczkowska, ... Clinical endocrinology 80 (4), 478-486, 2014 | 124 | 2014 |
| Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion A Geroula, T Deutschbein, K Langton, J Masjkur, C Pamporaki, ... European Journal of Endocrinology 181 (4), 409-420, 2019 | 110 | 2019 |
| Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma D Rao, M Peitzsch, A Prejbisz, K Hanus, M Fassnacht, F Beuschlein, ... European journal of endocrinology 177 (2), 103-113, 2017 | 106 | 2017 |
| Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine G Eisenhofer, M Peitzsch, D Kaden, K Langton, A Mangelis, C Pamporaki, ... Clinica chimica acta 490, 46-54, 2019 | 77 | 2019 |
| Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma G Eisenhofer, T Deutschbein, G Constantinescu, K Langton, C Pamporaki, ... Clinical Chemistry and Laboratory Medicine (CCLM) 59 (2), 353-363, 2021 | 55 | 2021 |
| Biochemical assessment of pheochromocytoma and paraganglioma G Eisenhofer, C Pamporaki, JWM Lenders Endocrine reviews 44 (5), 862-909, 2023 | 54 | 2023 |
| Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study PS Reel, S Reel, JC van Kralingen, K Langton, K Lang, Z Erlic, CK Larsen, ... EBioMedicine 84, 2022 | 40 | 2022 |
| Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma C Pamporaki, T Prodanov, L Meuter, AMA Berends, N Bechmann, ... European Journal of Cancer 169, 32-41, 2022 | 38 | 2022 |
| A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position J Boyd, AA Leung, HSM Sadrzadeh, C Pamporaki, K Pacak, ... European journal of endocrinology 181 (3), 301-309, 2019 | 36 | 2019 |
| Silent pheochromocytoma and paraganglioma: systematic review and proposed definitions for standardized terminology G Constantinescu, C Preda, V Constantinescu, T Siepmann, SR Bornstein, ... Frontiers in endocrinology 13, 1021420, 2022 | 33 | 2022 |
| Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort C Pamporaki, AMA Berends, A Filippatos, T Prodanov, L Meuter, ... The Lancet Digital Health 5 (9), e551-e559, 2023 | 32 | 2023 |
| Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine S Richter, B Qiu, M Ghering, C Kunath, G Constantinescu, C Luths, ... Endocrine-Related Cancer 29 (4), 213-224, 2022 | 32 | 2022 |
| Targeted metabolomics as a tool in discriminating endocrine from primary hypertension Z Erlic, P Reel, S Reel, L Amar, A Pecori, CK Larsen, M Tetti, C Pamporaki, ... The Journal of Clinical Endocrinology & Metabolism 106 (4), e1111-e1128, 2021 | 31 | 2021 |
| The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism LA Lazaros, EG Hatzi, CE Pamporaki, PI Sakaloglou, NV Xita, ... Journal of assisted reproduction and genetics 29, 1185-1191, 2012 | 30 | 2012 |
| Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma C Pamporaki, M Bursztyn, M Reimann, T Ziemssen, SR Bornstein, ... European journal of endocrinology 170 (3), 349-357, 2014 | 29 | 2014 |
| Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled … E Baudin, B Goichot, A Berruti, J Hadoux, S Moalla, S Laboureau, ... The Lancet 403 (10431), 1061-1070, 2024 | 28 | 2024 |
| Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses A Fischer, S Kloos, U Maccio, J Friemel, H Remde, M Fassnacht, ... The Journal of Clinical Endocrinology & Metabolism 108 (10), 2676-2685, 2023 | 28 | 2023 |
Graeme EisenhoferProfessor and Chief, Division of Clinical Neurochemistry, Technische Universität DresdenEmail được xác minh tại uniklinikum-dresden.de
